سرطان استخوان: سرطان‌های اولیه استخوان و متاستازهای استخوانی

__Bone Cancer,__ __2nd Edition__ comprehensively investigates key discoveries in the field of bone biology over the last five years that have led to the development of entirely new areas for investigation, such as therapies which combine surgery and biological approaches. The Second Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with key chapters from the first edition, and offers numerous new chapters describing the new concepts of bone cancer biology and therapy, for both primary bone tumors as well as bone metastases. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials. Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. **Bone Cancer** continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases - from bench to bedside: development (cellular and molecular mechanisms), genomic and proteomic analyses, clinical analyses (histopathology, imaging, pain monitoring), as well as new therapeutic approaches and clinical trials for primary bone tumors and bone metastases. * Presents a comprehensive, translational source for all aspects of primary bone cancer and bone metastases in one reference work * Provides a common language for cancer researchers, bone biologists, oncologists, and radiologists to discuss bone tumors and how bone cancer metastases affects each major organ system * Offers insights to research clinicians (oncologists and radiologists) into understanding the molecular basis of bone cancer, leading to more well-informed diagnoses and treatment of tumors and metastases * Offers insights to bone biologists into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays Content: Front matter, Pages i-iii Copyright, Page iv List of Contributors, Pages xi-xv, Catherine Alix-Panabieres, Matthias J.E. Arlt, Regis Bataille, Gillian Bedard, Dominik R. Berthold, Paolo Bianco, Frédéric Blanchard, Jean-Yves Blay, Damien Bolton, Marina Bolzoni, Walter Born, Sander M. Botter, Corinne Bouvier, Bénédicte Brounais-Le Royer, Nicola J. Brown, Jeroen T. Buijs, Daniel F. Camacho, Preston Campbell, Daniel Chappard, Stephane Chartier, Hong Chou, et al. Foreword, Pages xvii-xviii, Jean-Jacques Body, T. John Martin Preface, Page xix Chapter 1 - Epidemiology of primary bone tumors and economical aspects of bone metastases, Pages 5-10, Esther I. Hauben, Pancras C.W. Hogendoorn Chapter 2 - Tumor–bone interactions: there is no place like bone, Pages 13-28, Pierrick G.J. Fournier, Patricia Juárez, Theresa A. Guise Chapter 3 - Stem cell niches in the bone–bone marrow organ and their significance for hematopoietic and non-hematopoietic cancer, Pages 29-37, Mara Riminucci, Benedetto Sacchetti, Paolo Bianco Chapter 4 - Deregulation of osteoblast differentiation in primary bone cancers, Pages 39-54, Pierre J. Marie, Olivia Fromigué, Dominique Modrowski Chapter 5 - Contribution of osteoclasts to the bone–tumor niche, Pages 55-63, James R. Edwards Chapter 6 - Involvement of osteocytes in cancer bone niche, Pages 65-72, Evangelos Terpos, Dimitrios Christoulas Chapter 7 - Role of mesenchymal stem cells in bone cancer; initiation, propagation and metastasis, Pages 73-82, Anne-Marie Cleton-Jansen Chapter 8 - Gap junction in bone remodeling and in primary bone tumors: osteosarcoma and Ewing sarcoma, Pages 83-89, Julie Talbot, Audrey Lamora, Verena Stresing, Franck Verrecchia Chapter 9 - Macrophages and pathophysiology of bone cancers, Pages 91-101, Sofia Sousa, Jorma A. Määttä Chapter 10 - Cytokines and bone cancers, Pages 103-110, Bénédicte Brounais-Le Royer, Frédéric Blanchard Chapter 11 - Technical aspects: how do we best prepare bone samples for proper histological analysis?, Pages 111-120, Daniel Chappard Chapter 12 - Bone remodeling markers and bone cancer, Pages 123-138, Markus J. Seibel Chapter 13 - Cancer stem cells in representative bone tumors: osteosarcoma, Ewing sarcoma and metastases from breast and prostate carcinomas, Pages 139-148, Valèrie Trichet Chapter 14 - Homeobox genes from the Dlx family and bone cancers, Pages 149-162, Benjamin Navet, Frédéric Lézot Chapter 15 - MicroRNA implication in therapeutic resistance and metastatic dissemination of bone-associated tumors, Pages 163-176, Lidia Rodriguez, Camille Jacques, Benjamin Ory Chapter 16 - Hypoxia and angiogenesis: from primary tumor to bone metastasis, Pages 177-189, Kimberley J. Reeves, Nicola J. Brown Chapter 17 - Modeling osteosarcoma: in vitro and in vivo approaches, Pages 195-204, Carl R. Walkley Chapter 18 - Stemness markers of osteosarcoma, Pages 205-211, Virginia Tirino, Francesca Paino, Federica Papaccio, Marcella La Noce, Gianpaolo Papaccio, Vincenzo Desiderio Chapter 19 - Molecular pathology of osteosarcoma, Pages 213-222, Shuko Harada, Shi Wei, Gene P. Siegal Chapter 20 - Gene and proteomic profiling of osteosarcoma, Pages 223-234, Ana Patiño-García, Fernando Lecanda Chapter 21 - Ewing sarcoma family of tumors, Pages 235-244, Joseph Ludwig Chapter 22 - Biology of Ewing sarcoma, Pages 245-255, Franck Tirode Chapter 23 - Osteoclast-rich lesions of bone: a clinical and molecular overview, Pages 257-272, Adrienne M. Flanagan, Roberto Tirabosco, Panagiotis D. Gikas Chapter 24 - Markers for bone sarcomas, Pages 273-285, Gonzague de Pinieux, Anne Gomez-Brouchet, Corinne Bouvier Chapter 25 - Margins and bone tumors – what are we talking about?, Pages 287-291, François Gouin, Marie-Françoise Heymann Chapter 26 - Cytogenetics of bone tumors, Pages 293-303, Jiyun Lee, Andrea R. Sternenberger, Shibo Li Chapter 27 - Genetic aspects of bone tumors, Pages 305-318, Shamini Selvarajah, Paul C. Park, Maria Zielenska, Jeremy A. Squire Chapter 28 - Cytogenetic and molecular genetic alterations in bone tumors, Pages 319-339, Tarja Niini, Sakari Knuutila Chapter 29 - Genetics of giant cell tumors of bone, Pages 341-345, Bertrand Isidor, Guillaume Odri, François Gouin, Marie-Françoise Heymann Chapter 30 - Mammalian models of bone sarcomas, Pages 349-363, Sander M. Botter, Matthias J.E. Arlt, Walter Born, Bruno Fuchs Chapter 31 - Zebrafish models for studying bone cancers: mutants, transgenic fish and embryos, Pages 365-370, Anne-Marie Cleton-Jansen Chapter 32 - Imaging of bone sarcomas, Pages 371-392, Himabindu Mikkilineni, Hakan Ilaslan, Murali Sundaram Chapter 33 - New therapeutic targets in Ewing sarcoma: from pre-clinical proof-of-concept to clinical trials, Pages 393-405, Nadège Corradini, Françoise Redini Chapter 34 - Therapeutic approaches for bone sarcomas, Pages 407-414, Andreas F. Mavrogenis, Pietro Ruggieri Chapter 35 - Chondrosarcoma of bone: diagnosis and therapy, Pages 415-424, Arne Streitbuerger, Georg Gosheger, Jendrik Hardes Chapter 36 - Apoptosis and drug resistance in malignant bone tumors, Pages 425-436, Udo Kontny, Andrej Lissat Chapter 37 - Giant cell tumors of bone, Pages 437-445, Olfa Derbel, Jean-Yves Blay Chapter 38 - EMT process in bone metastasis, Pages 451-459, Dingcheng Gao, Erik W. Thompson, Vivek Mittal Chapter 39 - Histopathology of skeletal metastases, Pages 461-470, Ping Tang, David G. Hicks Chapter 40 - Disseminated tumor cells in bone marrow of cancer patients, Pages 471-477, K. Pantel, Catherine Alix-Panabieres Chapter 41 - MicroRNA-mediated regulation of bone metastasis formation: from primary tumors to skeleton, Pages 479-489, Martine Croset, Philippe Clézardin Chapter 42 - Myeloma and osteoclast relationship, Pages 491-500, Nicola Giuliani, Marina Bolzoni, Regis Bataille Chapter 43 - In vivo models used in studies of bone metastases, Pages 503-518, Ingunn Holen, Michelle A. Lawson Chapter 44 - Interventional radiologic techniques in management of bone tumors, Pages 519-536, Clemens Reisinger, Paul I. Mallinson, Hong Chou, Peter L. Munk, Hugue A. Ouellette Chapter 45 - Diagnosis of bone metastases in urological malignancies – an update, Pages 537-556, Nathan Lawrentschuk, Nieroshan Rajarubendra, Damien Bolton Chapter 46 - Pre-clinical molecular imaging of “the seed and the soil” in bone metastasis, Pages 557-570, Geertje van der Horst, Jeroen T. Buijs, Gabri van der Pluijm Chapter 47 - Mechanisms and management of bone cancer pain, Pages 571-577, Patrick W. O’Donnell, Denis R. Clohisy Chapter 48 - Bone cancer: current opinion in palliative care, Pages 579-589, Patrick W. Mantyh, Michelle L. Thompson, Stephane Chartier, Michelle Fealk Chapter 49 - Involvement of sympathetic nerves in bone metastasis, Pages 591-597, Florent Elefteriou, Preston Campbell Chapter 50 - Pain control with palliative radiotherapy in patients with bone metastases, Pages 599-613, Marko Popovic, Ronald Chow, Nicholas Lao, Gillian Bedard, Edward Chow Chapter 51 - Cellular and molecular actions of bisphosphonates, Pages 615-627, Simon Junankar, Michael J. Rogers Chapter 52 - The use of nitrogen-bisphosphonates to capture the potent anti-tumor arsenal of human peripheral blood γδ T cells for the treatment of bone cancer metastasis, Pages 629-636, Shirin Kalyan, Wei He, Dieter Kabelitz Chapter 53 - Systemic treatment of bone metastases in castration-resistant prostate cancer (CRPC): pre-clinical to clinical point of view, Pages 637-646, Christian Thomas, Francois Lamoureux Chapter 54 - A multi-targeted approach to treating bone metastases, Pages 647-655, Daniel F. Camacho, Kenneth J. Pienta Chapter 55 - Bone metastases in prostate cancer: pathophysiology, clinical complications, actual treatment, and future directions, Pages 657-663, Fernanda G. Herrera, Thomas Tawadros, Dominik R. Berthold Chapter 56 - Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases, Pages 665-675, Alexander H.G. Paterson Chapter 57 - Bone metastases – current status of bone-targeted treatments, Pages 677-683, Robert Coleman Chapter 58 - Bone metastases, clinical trials II: zoledronic acid and denosumab in the prevention of bone metastases, Pages 685-689, Michael Gnant Index, Pages 691-709 The epidemiological and clinical importance of bone metastasis has long been recognized, but the past decade has seen an explosion in the fields of bone biology and bone cancer research. This period of time has been marked by a number of key discoveries that have led to the opening up of entirely new areas for investigation as well as new therapies which combine surgery and biological therapeutic approaches. Bone is a common site of cancer metastases - cancer cells commonly develop in bone and spread to other organ systems through the bloodstream. For example, the incidence of bone metastases in breast and prostate cancers is 70%, whereas it is only 30 to 40% in metastatic lung cancer. In clinical terms, bone metastases have substantial negative effects on a patient's quality of life and are a main cause of patient mortality. Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for the medical and cancer research communities.^ This book provides, all in one resource, the most recent data on bone cancer development (cellular and molecular mechanisms), genomic and proteomic analyses, clinical analyses (histopathology, imaging, pain monitoring), as well as new therapeutic approaches and clinical trials for primary bone tumors and bone metastases. Feature Presents a comprehensive, translational source for all aspects of bone cancer in one reference work Bone cancer experts (from all areas of research and practice) take readers from the bench research (cellular and molecular mechanism), through genomic and proteomic analysis, all the way to clinical analysis (histopathology and imaging) and new therapeutic approaches.^ Clear presentation by bone biologists of the cellular and molecular mechanisms underlying bone tumors and bone cancer metastasis as well as the genomic and proteomic assays used in detecting cancer within given organ systems Clear presentation by oncologists and radiologists of how histopathology, imaging, and pain monitoring can lead to new therapeutic approaches Benefit Saves researchers and clinicians time in quickly accessing the very latest details on a broad range of bone cancer issues, as opposed to searching through thousands of journal articles.^ Provides a common language for cancer researchers, bone biologists, oncologists, and radiologists to discuss bone tumors and how bone cancer metastases affects each major organ system Correct diagnosis (and therefore correct treatment) of cancer depends on a strong understanding of the molecular basis for the disease - both oncologists and radiologists will benefit Bone biologists will gain insight into how clinical observations and practices can feed back into the research cycle and will, therefore, be able to develop more targeted genomic and proteomic assays.

Bone Cancer, 2nd Edition comprehensively investigates key discoveries in the field of bone biology over the last five years that have led to the development of entirely new areas for investigation, such as therapies which combine surgery and biological approaches. The Second Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with key chapters from the first edition, and offers numerous new chapters describing the new concepts of bone cancer biology and therapy, for both primary bone tumors as well as bone metastases. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials. Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. Bone Cancer continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases – from bench to bedside: development (cellular and molecular mechanisms), genomic and proteomic analyses, clinical analyses (histopathology, imaging, pain monitoring), as well as new therapeutic approaches and clinical trials for primary bone tumors and bone metastases.

• Presents a comprehensive, translational source for all aspects of primary bone cancer and bone metastases in one reference work
• Provides a common language for cancer researchers, bone biologists, oncologists, and radiologists to discuss bone tumors and how bone cancer metastases affects each major organ system
• Offers insights to research clinicians (oncologists and radiologists) into understanding the molecular basis of bone cancer, leading to more well-informed diagnoses and treatment of tumors and metastases
• Offers insights to bone biologists into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays

Bone Cancer, Second Edition comprehensively investigates key discoveries in the field of bone biology over the last five years that have led to the development of entirely new areas for investigation, such as therapies which combine surgery and biological approaches. The Second Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with key chapters from the first edition, and offers numerous new chapters describing the new concepts of bone cancer biology and therapy, for both primary bone tumors as well as bone metastases. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials. Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. Bone Cancer continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases – from bench to bedside: development (cellular and molecular mechanisms), genomic and proteomic analyses, clinical analyses (histopathology, imaging, pain monitoring), as well as new therapeutic approaches and clinical trials for primary bone tumors and bone metastases. Presents a comprehensive, translational source for all aspects of primary bone cancer and bone metastases in one reference work Provides a common language for cancer researchers, bone biologists, oncologists, and radiologists to discuss bone tumors and how bone cancer metastases affects each major organ system Offers insights to research clinicians (oncologists and radiologists) into understanding the molecular basis of bone cancer, leading to more well-informed diagnoses and treatment of tumors and metastases Offers insights to bone biologists into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays Bone Cancer, 2 nd Edition comprehensively investigates key discoveries in the field of bone biology over the last five years that have led to the development of entirely new areas for investigation, such as therapies which combine surgery and biological approaches. The Second Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with key chapters from the first edition, and offers numerous new chapters describing the new concepts of bone cancer biology and therapy, for both primary bone tumors as well as bone metastases. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials. Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. Bone Cancer continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases - from bench to bedside: development (cellular and molecular mechanisms), genomic and proteomic analyses, clinical analyses (histopathology, imaging, pain monitoring), as well as new therapeutic approaches and clinical trials for primary bone tumors and bone metastases. Presents a comprehensive, translational source for all aspects of primary bone cancer and bone metastases in one reference work Provides a common language for cancer researchers, bone biologists, oncologists, and radiologists to discuss bone tumors and how bone cancer metastases affects each major organ system Offers insights to research clinicians (oncologists and radiologists) into understanding the molecular basis of bone cancer, leading to more well-informed diagnoses and treatment of tumors and metastases Offers insights to bone biologists into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays